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Associated with Decreased Ifn-c/Il-17a and Increased Il-6/
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Abstract
In a cross sectional study, 19 French and 23 Colombian cases of confirmed active ocular toxoplasmosis (OT) were evaluated.
The objective was to compare clinical, parasitological and immunological responses and relate them to the infecting strains.
A complete ocular examination was performed in each patient. The infecting strain was characterized by genotyping when
intraocular Toxoplasma DNA was detectable, as well as by peptide-specific serotyping for each patient. To characterize the
immune response, we assessed Toxoplasma protein recognition patterns by intraocular antibodies and the intraocular
profile of cytokines, chemokines and growth factors. Significant differences were found for size of active lesions, unilateral
macular involvement, unilateral visual impairment, vitreous inflammation, synechiae, and vasculitis, with higher values
observed throughout for Colombian patients. Multilocus PCR-DNA sequence genotyping was only successful in three
Colombian patients revealing one type I and two atypical strains. The Colombian OT patients possessed heterogeneous
atypical serotypes whereas the French were uniformly reactive to type II strain peptides. The protein patterns recognized by
intraocular antibodies and the cytokine patterns were strikingly different between the two populations. Intraocular IFN-c
and IL-17 expression was lower, while higher levels of IL-13 and IL-6 were detected in aqueous humor of Colombian
patients. Our results are consistent with the hypothesis that South American strains may cause more severe OT due to an
inhibition of the protective effect of IFN-c.
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Introduction
Infection with the protozoan parasite Toxoplasma gondii is a
leading cause of visual impairment in numerous countries, being
responsible for 30 to 50% of uveitis cases in immunocompetent
individuals [1]. Ocular toxoplasmosis (OT) is a potential
complication of both acquired and congenital toxoplasmosis [2].
The incidence of ocular toxoplasmosis has been estimated in
Colombia (Quindio region) to be of three new episodes by 100 000
inhabitants by year [3], while in British-born patients it has been
estimated to be 0.4 cases per 100,000 population per year and the
lifetime risk of disease to be 18 cases per 100,000 population [4].
In a Colombian study, 5.5% of the population in the province
of Quindı´o exhibited retinochoroidal scars resulting from a
postnatally acquired infection, with 20% of this group presenting
reduced visual capacity. [3,5]. In a retrospective study on uveitis
conducted in 693 Colombian patients, 417 of whom had a definitive
diagnosis, toxoplasmosis was the most frequent cause with 276 cases
(39.8%) followed by idiopathic uveitis and toxocariasis [6].
Some differences between South American and European
clinical case series were observed in terms of congenital
transmission rates, probability of symptoms in congenital OT
[7,8], severity of ocular inflammation [9] and intraocular specific
antibody levels [10]. However, no comparative clinical and
biological studies have been performed yet in patients from both
continents with laboratory-confirmed OT.
The population structure of T. gondii in North America and
Europe includes three highly prevalent clonal lineages, Types I
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(haplogroup 1, Clade A), II (Haplogroup 2, Clade D), and III
(haplogroup 3, Clade, C) which differ greatly in virulence in the
mouse model. The vast majority of human and animal infections
are caused by the relatively avirulent Type II strains. In contrast,
heterogeneous atypical genotypes of T. gondii are associated with
severe infections in humans in South America. They belong to
various haplogroups: 4, 5, 8 10 and 15, Clade F [11,12][13].
The high genetic diversity of Toxoplasma strains in the tropical
zone of the Americas may partly explain why congenital
toxoplasmosis is more symptomatic in South America than
Europe, as was demonstrated in cohorts of congenitally infected
children from different continents [8,14,15]. A comparative
prospective cohort study of congenitally infected children in
Brazil and Europe found that Brazilian children displayed eye
lesions that were larger, more numerous, and more likely to
affect the central part of the retina responsible for acute vision
[7]. Anecdotal clinical cases were also reported in the literature,
such as a severe atypical bilateral retinochoroiditis in a Brazilian
patient, caused by a highly divergent, non-archetypal T. gondii
strain [16].
Given the markedly different population structure of T. gondii in
Europe and South America, it is relevant to study the implications
of this diversity on human pathogenesis [17]. Therefore, we
conducted a multicenter case series study in order to compare the
different clinical and immunological characteristics between
Colombian and French patients, collecting the same data and
performing the same laboratory assays in patients with biologically
confirmed OT. The findings were related to Toxoplasma strain
genotyping and peptide-based strain serotyping in our patients.
Materials and Methods
Study population
We collected data from consecutive patients who consulted at
the Departments of Ophthalmology at Strasbourg University
Hospital (France) and Quindı´o University Health Center (Arme-
nia, Colombia) between August 2008 and August 2010. Both
departments were tertiary-level centers able to perform anterior
chamber paracentesis. For both patient populations, a complete
ocular examination was conducted, including best-corrected
Snellen visual acuity, slit-lamp biomicroscopy, tonometry, and
indirect ophthalmoscopy. The clinical diagnosis of OT was based
on criteria previously described by G. Holland [6,18]. Screened
patients with clinically suspected OT and seropositive for anti-
Toxoplasma immunoglobulin G (IgG) antibodies were subsequently
submitted to biological investigations to assess the local presence of
Toxoplasma DNA and/or the intraocular antibody synthesis [19] to
confirm OT.
Ethics statement
Ethics Committee/Institutional Review Board (IRB) approval
were obtained from Hoˆpitaux Universitaires de Strasbourg
(PHRC 2007/3964) and Quindio University (ACT 14, 2008/23-
06). Written informed consent was obtained from all subjects.
Clinical evaluation criteria
We analyzed the clinical characteristics of 19 French and 23
Colombian patients with active uveitis and biologically confirmed
OT. Patients who were immunocompromised, suffered from other
ocular infections, or received local or systemic anti-Toxoplasma
treatment for active uveitis, were excluded. An assessment of the
inflammation level and anatomic classification of uveitis was
carried out according to the criteria proposed by the International
Uveitis Study Group (IUSG) [20]. The size of the retinochoroidal
lesions was measured in disc-diameters (dd).
Sample collection and biological OT diagnosis
Paired samples of aqueous humor and serum were obtained
from each subject at the time of clinical diagnosis for laboratory
analysis. The Colombian samples were stored locally at 280uC
and then shipped together on dry ice to Strasbourg for laboratory
analysis. Aqueous humor samples (100–150 mL) were collected
through anterior chamber paracentesis and stored, along with
serum samples, at 280uC until analysis. The diagnosis of OT was
first confirmed by real-time PCR detection of Toxoplasma DNA
[21]. Positive PCR results were quantified using a standard curve
with serial 10-fold dilutions from a calibrated suspension of T.
gondii RH-Strain DNA. For PCR negative patients, immunoblot
(IB) was performed in order to detect intraocular synthesis of
Toxoplasma-specific antibodies (LDBIO Diagnosis, Lyon, France).
If both PCR and IB were unconclusive, a modified Goldmann-
Witmer test was used to prove intraocular specificantibody
synthesis [22].
Cytokine-Chemokine Profile measurement in aqueous
humor
The Bio-Plex Human 27-Plex Cytokine Panel assay (Bio-Rad,
Marne-la-Coquette, France) was used according to the manufa-
curer’s recommendations to measure cytokine and chemokine
levels in aqueous humor. The assay plate layout consisted in a
standard series in duplicate (1 to 32 000 pg/mL), four blank wells
and 20 mL duplicates of AqH samples, diluted to 50 mL with
BioPlex Human serum diluent [23]. A set of Toxoplasma
seropositive cataract patients were used as control, 9 Colombian
and 10 French. Data were analyzed with Bio-Plex Manager TM
software V1.1.
Toxoplasma strain genotyping analysis
DNA extraction for genotyping analysis was performed directly
on ocular fluid samples and indirectly on infected cell cultures for
six reference strains. GT1, PTG, and CTG strains were selected as
reference Types I, II, and III strains, respectively. TgCtCo02,
TgCtCo05, and TgCtCo07 strains were selected as reference
Colombian strains [24,25]. T. gondii DNA samples were subjected
to genotyping analysis with 15 microsatellite markers in a
multiplex PCR assay, as described elsewhere [26].
Author Summary
Ocular toxoplasmosis (OT), due to protozoan parasite
Toxoplasma gondii, is a potential complication of both
acquired and congenital infection, leading to visual
impairment in numerous countries and being responsible
for 30 to 50% of uveitis cases in immunocompetent
individuals. In this study we confirmed the presence of
more severe ocular toxoplasmosis in a tropical setting of
Colombia, when compared to France. The main hypothesis
for these clinical differences is based on the idea that
severe disease in humans may result from poor host
adaptation to neotropical zoonotic strains of T. gondii
Indeed, our results are consistent with the hypothesis that
South American strains may cause more severe OT due to
an inhibition of the intraocular protective immune
response.
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Toxoplasma strain serotyping analysis
Serotyping of Toxoplasma infections was performed using 5
polymorphic synthetic peptides derived from the T. gondii dense
granule proteins (GRA), GRA6 and GRA7. This test detects the
presence of strain specific antibodies raised against Type II or non-
Type II GRA6/7 alleles in patients infected with Type II or non
Type II (NE-II) parasites respectively, as previously described
[14,27]. Briefly, the ELISA results presented are an optical density
(OD) index obtained by dividing the OD value at 405 nm for each
of the 5 serotyping peptides by the mean of the OD readings for
the 2 control peptides. Threshold values are determined by
averaging the normalized OD ratio from 100 seronegative French
samples and adding 2 standard deviations, above which normal-
ized values are considered positive. Obtained results are divided in
four populations depending on their reactivity to the 5 peptides: I/
III, ATYP, no reactivity (NR), and II [28]. I/III, ATYP and NR
are considered as NE-II [14]. Sera from pregnant women, tested
Toxoplasma seropositive in our laboratories, were used to assess the
Toxoplasma serotype in a larger population from each country, 45
serum samples from Colombia and 100 from France.
Statistical analysis
Mann-Whitney test followed by Dunn’s Multiple Comparison
test was applied for comparison of clinical and laboratory
characteristics for French and Colombian patients with confirmed
active ocular toxoplasmosis (P values,0.05 were considered
statistically significant; Stata software, College Station (Tx)
USA). Fisher’s exact test was used to compare diagnostic
performances of IB and PCR as well as the serotype prevalence.
Wilcoxon matched-pairs signed rank test was performed to
compare IB patterns. Mann-Whitney test was used to compare
intraocular parasite loads (P values,0.05 were considered
statistically significant. Kruskal-Wallis test followed by Dunn’s
Multiple Comparison test were applied for comparison of cytokine
and chemokine levels in aqueous humor between control and OT
populations in both countries (P values,0.05 were considered
statistically significant) (GraphPad Prism, La Jolla, CA, USA).
Results
Clinical characteristics
The clinical findings for OT patients are summarized in Tables 1
and S1. Statistically significant differences between groups were
found for eight parameters, being higher in Colombian patients
in all cases: i) time between consultation and anterior chamber
paracentesis (p= 0.02); ii) size of active lesions (p=0.04); iii)
unilateral macular involvement (p=0.001); iv) unilateral visual
impairment (p=0.04); v) vitreous inflammation (p=0.00001); vi)
percentage of patients with synechiae (p=0.04); vii) vasculitis
(p= 0.04) and viii) bilateral involvement (p=0.04). In addition,
there was a trend towards higher values for the Colombian patients
regarding the number of lesions, number of recurrences, and
intraocular pressure (IOP), although these differences were not
statistically significant. We conducted a stratified analysis in order to
exclude the influence of time before anterior chamber paracentesis
as a possible cause of the differences in clinical findings. We
compared early (,20 days after symptom onset) and late consulta-
tions (.20 days after symptom onset). As shown in Table 2 and
supplementary figure 1, most significant clinical differences between
the populations were also visible when comparing only the early-
consultant groups.
Detection of Toxoplasma DNA in aqueous humor and
strain genotyping analysis
In Colombians, aqueous humor samples revealed the presence of
T. gondiiDNA in 11 out of 23 samples (47.8%). In French patients,T.
gondii DNA could be detected in aqueous humor samples of 7 out of
19 patients (36.8%). This difference was not statistically significant.
In contrast, parasite loads in aqueous humor were significantly
higher in Colombian patients, 4.53 parasites 6 2 per 100 mL versus
0.3560.13 parasites per 100 mL (p= 0.0006) (Figure 1). Aqueous
humor samples from all French patients and 14 Colombian patients
had an insufficient amount of T. gondii DNA for genotyping analysis.
Only 9 Colombian ocular fluid samples were submitted for
multilocus PCR-DNA sequence genotyping analysis. Six had
unsuccessful PCR amplification for all 15 tested markers due to
low T. gondii DNA concentration. The genotype of one clinical
sample (case COL-#6) was closely related to a Type I strain, but
harboring unique alleles at three MS loci, M102, N83 and AA, using
15 amplified markers (Table 3). Of note, the genotype of a reference
Colombian isolate (TgCtCo07) collected from a cat in 2005 was also
Type I-like, suggesting that Type I-like strains may not be
uncommon in animals and humans in Colombia. The genotypes
of the other two clinical samples (cases COL-#26 and COL-#38)
could not be fully determined, with only four and five successfully
amplified markers, respectively. However, the results of the amplified
markers showed that both genotypes were different from the Type II
or III strains, which are common in North America and Europe.
They present a majority of Type I alleles (case COL-#26), like
TgCtCo07 but distinct at the N61 marker, and a combination of
Table 1. Comparative clinical and laboratory characteristics for French and Colombian patients with confirmed active ocular
toxoplasmosis (all cases).
CLINICAL CHARACTERISTICS FRANCE (n=19) COLOMBIA (n =23) P-value
Mean/n(%)* Median (Range) Mean/n(%)* Median (Range)
Age at consultation 45.22 44.5 (16–77) 38.3 37 (20–86) 0.23
Evolution time (days) 15 6 (1–150) 46 15 (4–240) 0.02
Macular involvement 2 (10.53%) N.A. N.A. 13 (56.52%) N.A. N.A. 0.001
Vitreous inflammation Level(+)** 0.95 2 (0–1) 2.41 2 (0–4) 0.00001
Synechia 2 (5.26%) N.A. N.A. 11 (47.8%) N.A. N.A. 0.04
Mann and Whitney test followed by Bonferroni-Dunn’s Multiple Comparison test was applied (P values,0.05 were considered statistically significant)
*Percentages take into account only the patients with available information
**Measured according to Standardization Uveitis Nomenclature (SUN)
N.A. = Not applicable (for categorical variables)
doi:10.1371/journal.pntd.0002541.t001
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Type I, III, and atypical alleles (case COL-#38), like TgCtCo02 and
TgCtCo05, but again distinct at the N60 and N82 genetic markers.
Detection of intraocular anti-Toxoplasma antibodies
IB detected local antibody production in 19/23 Colombian
(82.6%) and 13/19 French (68.4%) patients (not significant).
However, a significant difference was observed in number of bands
and their recognition pattern of Toxoplasma proteins (p,0.0001)
(Figure 2). Specific proteins were recognized in 3.3% to 63.3% of
Colombian patients and 3.8% to 53.8% of French patients.
Colombian patients recognized most frequently a 62 kDa protein,
observed in 63.3% of patients. In French patients, the most frequently
detected protein was at 34.2 kDa, found in 53.8% of patients.
Toxoplasma strain serotyping analysis
As the amount of aqueous humor was insufficient for Toxoplasma
strain typing using an ELISA peptide-based assay, we decided to
serotype these patients using their sera. Ten OT patients from
each center were assessed, all from the early consultation group.
Among the Colombian patients, no Type II serotype was detected.
We found 4 I/III, one atypical and 5 non reactive (NR) serotypes
(Table 4). In contrast, all tested French OT patients showed Type
II serotypes except one patient with an atypical serotype. These
patterns were significantly different between the two groups
(p,0.0001). The two cases COL#26 and COL#38, found as
suspected Type I and Type I/III by genotyping, were serotyped as
NR and type I/III, respectively (Table 4).
To test if certain T. gondii strains are associated with OT, we
determined the overall distribution of serotypes in infected non-OT
control populations from both countries. Among the 45 Colombian
control patients, only 6 subjects (13.3%) had a type II whereas 39
(86.6%) had NE-II serotypes, which were subdivided in 6 NR, 29
type I/III and 4 atypical serotypes. Of 100 French control patients,
we found 64 (64%) type II, and 36 (36%) with NE-II; 10 NR, 2 type
I/III and 24 atypical serotypes. No statistically significant differ-
ences were observed between the control and OT groups in
Colombian patients, however we found a significant difference
Figure 1. Parasite load in PCR positive patients. Aqueous humor
was obtained from French and Colombian OT patients, DNA extracted,
and the number of parasites per mL aqueous humor determined by
quantitative PCR using Toxoplasma-specific primers. The Mann and
Whitney test was significant (P = 0.0002).
doi:10.1371/journal.pntd.0002541.g001
Table 3. Genotyping results of T. gondii DNA from 6 reference strains and 9 Colombian human ocular fluid samples with 15
microsatellite markers in a single multiplex PCR assay.
Typea Isolateb Origin (Host)c Microsatellite markers
d
TUB2 W35 TgM-A B18 B17 M33 IV.1 XI.1 M48 M102 N60 N82 AA N61 N83
I GT1 (Reference) USA (Goat) 291 248 209 160 342 169 274 358 209 168 145 119 265 87 306
II PTG (Reference) USA (Sheep) 289 242 207 158 336 169 274 356 215 174 142 111 265 91 310
III CTG (Reference) USA (Cat) 289 242 205 160 336 165 278 356 215 190 147 111 269 89 312
Atypical TgCtCo02 (Reference) Colombia (Cat) 291 248 205 160 342 167 274 358 209 166 142 123 291 89 306
Atypical TgCtCo05 (Reference) Colombia (Cat) 291 242 205 160 336 165 276 356 223 166 142 121 279 87 304
I TgCtCo07 (Reference) Colombia (Cat) 291 248 209 160 342 169 274 358 209 166 147 127 265 87 306
ND COL-# 15) Colombia (Human, AH) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
ND COL-#2) Colombia (Human, AH) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
I COL-#6) Colombia (Human, AH) 291 248 209 160 342 169 274 358 209 166 145 117 269 87 306
ND COL-# 1) Colombia (Human, AH) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
ND COL-#24 Colombia (Human, AH) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
ND COL-#25 Colombia (Human, AH) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
ND COL-#26 Colombia (Human, AH) NA NA 209 160 NA NA NA NA NA NA NA 127 NA 89 NA
ND COL-#38 Colombia (Human, AH) NA 242 205 NA 342 NA NA NA NA NA 140 117 NA NA NA
ND COL-#41 Colombia (Human, AH) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
aND, Not Determined.
bPTG is a clone of the ME49 strain; CTG is also known as CEP or C strain. GT1, PTG, and CTG are reference type I, II, and III strains, respectively. TgCtCo02, TgCtCo05, and
TgCtCo07 are reference strains isolated from cats in Colombia. All DNA samples from reference strains were kindly provided by Chunlei Su and Jitender Dubey.
cAH, Aqueous Humor; VH, Vitreous Humor.
dNA, Not Amplified
doi:10.1371/journal.pntd.0002541.t003
Old and New World Ocular Toxoplasmosis
PLOS Neglected Tropical Diseases | www.plosntds.org 5 November 2013 | Volume 7 | Issue 11 | e2541
(P = 0.02) between the French control and OT populations, with
respect to the proportion of the two types, II and NE-II.
Ocular cytokine and chemokine pattern
Cytokines patterns in aqueous humor of OT patients were
compared to cataract controls (Figure 3 and Table S2 in Text S1).
Several immune mediators were augmented in French, as well as
in Colombian patients. In French patients, the Th1 type cytokines
IFN-c, IL-2 and IL-15 were expressed in all patients. This Th1
immune response was associated to a Th17 response with
increased IL-17 production. Additionally, we observed a large
proinflammatory response with increased levels of IL-6, IL-1b, IL-
8, MIP-1b, MCP-1 and G-CSF. These patients also possessed a
corresponding anti-inflammatory response was based on the
presence of IL-4, IL-10, and IL-1RA. In contrast, Colombian
patients had lower expression of major proinflammatory immune
modulators, including IFN-c, IL-15, IL-17, IL-2, IL-10, MIP-1b,
GM-CSF and G-CSF, with the exception of elevated TNF-a and
IL-6 levels. These patients also had elevated levels of the
counterregulating Th2-type cytokine IL-13.
Discussion
Previously published studies found differences between South
American and European clinical case series on adult patients in
terms of frequency of serological markers in OT [8], probability of
symptoms in congenital infection [7], as well as inflammation
levels and IOP [9]. However, these were mostly retrospective
evaluations of multiple studies. Their main limitation is their
inclusion of patients with ‘‘suspected’’ OT, rather than biologically
confirmed cases. While the ocular signs of toxoplasmic retinocho-
roiditis are highly suggestive of this disease, they may be mimicked
by other infections [22], while in some cases, the symptoms may be
atypical [19,29]. Therefore, we strengthened our evaluation by
inclusion of biologically confirmed OT cases only, as well as by
comparing the same bio-clinical data from two different popula-
tions of OT patients, located in South America and Europe in a
cross sectional study. Among the 17 criteria analyzed in the two
populations, the following were significantly higher in Colombian
patients: macular involvement, vitreous inflammation, strabismus,
bilateral involvement and synechiae. Our findings confirm and
expand the data from the retrospective study of Dodds et al. from
patients with biologically unconfirmed OT which found elevated
IOP, increased presence of synechiae, AC cells, flare, and vitreous
humor haze [9]. In our study, one key difference between the two
patient populations was the date of consultation, as Colombian
patients consulted later than the French. However, when our
analysis was stratified regarding this aspect, the observed clinical
differences remained significant.
Figure 2. Differences in pattern recognition by immunoblotting between Colombian and French patients. Aqueous humor samples
were tested against Toxoplasma proteins, as detailed in the Materials and methods section. The percentage of French or Colombian patients
recognizing the different Toxoplasma proteins is given. A Wilcoxon matched-pairs signed rank test was performed to compare IB patterns
(p,0.0001).
doi:10.1371/journal.pntd.0002541.g002
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Figure 3. Cytokine and chemokine levels (pg/mL) in aqueous humor for French and Colombian patients. Aqueous humor samples were
tested for ocular cytokines and chemokines as detailed in Material and methods section, for Colombian (OT-CO; n = 10) and French ocular
toxoplasmosis patients (OT-FR; n = 10). They were compared to cataract control groups from Colombia (CT-CO; n = 9) and France (CT-FR; n = 10).
Kruskal-Wallis test followed by Dunn’s Multiple Comparison test were applied for comparison between populations (significant for P,0.05).
doi:10.1371/journal.pntd.0002541.g003
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The main hypothesis for these clinical differences is based on
the idea that severe disease in humans may result from poor host
adaptation to neotropical zoonotic strains of T. gondii [11]. Our
study accumulated some clues supporting this hypothesis.
Central strain-specific parasite virulence factors in human
infections were revealed in the last years [30]. Their role in the
presence of more virulent parasite genotypes in South America
[11,12] is not yet thoroughly studied. Theses strains are rarely
found in Europe [31] where Type II genotypes predominate,
including in OT patients [32]. In the three Colombian OT
patients where we could detect Toxoplasma DNA, we found one
Type I and two atypical strains. The fact that no patient of the
French group had a sufficient ocular parasite load for genotyping
clearly shows the difference in ocular virulence. Additionally, we
noticed that intraocular antibodies responses showed major
differences in Toxoplasma antigen recognition by an immunoblot-
ting assay. Even if this could be partly due to better detection of
Toxoplasma Type I antigens used in this assay by Colombian
patients, other, host immune specific factors are certainly crucial
such as local antibodies, whose exact role and function should be
explored.
Our serotyping assay confirmed that Colombian and French
patients recognize different strain-specific epitopes. Colombian
OT patients recognized a heterogeneous pattern of strain specific
peptides, but none of them were from type II strains. The French
OT patients recognized only Type II strain specific peptides,
confirming the reliability of this test in a geographic region with
predominant type II strains infections [33]. The corresponding
control populations presented the same serological pattern for
Colombia, but a slightly different pattern for France, where some
sera were non reactive to Type II antigens. The difference may
due to the unequal sample sizes, so this point needs further
investigation using more samples and equilibrated OT and control
population. However, these data indicate that type II and non-
type II strains are able to cause ocular pathology, but with a
markedly different clinical picture. Concerning the Colombian
strains, current serotyping techniques might be not sensitive
enough to distinguish the highly variable strains.
When we looked at the patients’ local immunological reaction,
we observed clearly different cytokine signatures. In French
patients, the host-parasite relationship seems to be equilibrated
between protection and inflammation. The protective effect of
IFN-c is balanced by anti-inflammatory cytokines such as IL-2 and
IL-10. The role of IL-17 is controversial. We have previously
observed an early pathologic and parasite promoting role for IL-
17 in French patients and in an animal model infected by a Type
II Toxoplasma strain [34]. In the intraocular ocular environment,
IL-17 would attract neutrophils [35] and, accompanied by IL-15
and MIP-1b/CCL4, activates and attracts NK cells [36] and
monocytes [37]. All these innate immune cells might cause retinal
inflammation, but then permit to control Toxoplasma proliferation
[38,39]. As our recent findings implicate IL-27 and the Treg
subset in counterbalancing deleterious inflammatory Th17 type
responses [34], the corresponding mediators deserve to be
examined more closely in future studies.
In contrast, in the clinically more severe Colombian cases, IFN-
c and other major immunomodulators such as IL-17 were barely
detectable, while IL-6 and IL-13 were enhanced. Virulent strains
encode virulence factors able to modulate multiple immune host
cell signaling pathways through polymorphic effectors secreted
into the host cells such as ROP16 and GRA15 [38,40]. The
presence of Toxoplasma effector proteins from virulent strains
could explain the down-regulation of ocular IFN-c, leading to
higher ocular parasite loads in Colombian patients. The IL-17
down-regulation remains to be explained, but decreased levels of
IL-17 and other immune modulators, including proangiogenic
factors, could lead to a defect in the migration of leukocytes to the
eyes and be another explanation for impaired control of parasites
in the context of virulent South American infections. IL-6 could
also antagonize the anti-microbial properties of IFN-c by sustained
activation of STAT3, a potent inhibitor of IL-12 and IFN-c [41].
Down-regulation of IFN-c and its anti-Toxoplasma activity was also
observed for IL-13 in human fibroblasts [42]. It is important to
note here that Type I strains express a ROP16 allele associated
with prolonged activation of STAT3 and STAT6 signaling, which
may in part contribute to the increased IL-13 levels, whereas Type
II strains activate this pathway only transiently, allowing the
establishment of an inflammatory reaction [43]. This may
constitute the fundamental basis for the differential cytokine
response observed in our study.
The theory of local T cell exhaustion may be also of interest in
the settings of Colombian patients. Immune exhaustion is
characterized by the modification of the CD8+ functions by
reducing their polyfunctionality and their efficacy [44]. Indeed,
high Toxoplasma loads associated with a decreased IFN-c and IL-15
production and enhancement of TNF-a could be one aspect of this
loss of CD8+ T cell polyfunctionality. In contrast, in French
patients, elevated IL-15 is critical for homeostasis of memory CD8
T cells, and may lead to a better control of parasite proliferation
and subsequent parasite latency in the retina.
Taken together, our results indicate that virulent strains
observed in South America may suppress host-protective path-
ways, opening the way to multiplication and cytolytic activity of
the parasite in retinal tissues including blood vessels. The presence
of TNF-a in most of these patients could also contribute by
enhancing an ongoing immunopathological retinal process [45].
In contrast, in French patients, the cytokinic environment may
lead to the encystation of the parasite in the retinal tissues, leading
to subsequent recurrences.
Of course, for ethical reasons, we were only able to take one
time-point. Our results represent thus a snapshot of a developing
immune response. Additionally, a multifactorial origin of the
observed clinical and biological differences could not be excluded.
In our study, the source of contamination may have been drinking
water collected from surface water sources (i.e., rivers, lakes)
[46,47,48,49]. The more common macular involvement in
Colombian patients is often associated with congenital toxoplas-
mosis [6,15,50,51]. Even if we studied adult populations, we
cannot exclude a congenital origin of infection in some Colombian
patients. Moreover, acute toxoplasmosis was only diagnosed in 2
Colombian and 1 French case. The remaining population was
considered to exhibit chronic toxoplasmosis. Finally, individual
susceptibility was previously related to variations in various genes
encoding immune response players, such as IFN-c, IL-1a, IL-10,
TLR-9 or ABCA4, COL2A1, and P2X7-R [52,53,54,55]. These
genetically susceptible patients are possibly less able to cope with a
more virulent strain. Further investigations with larger cohorts
including an evaluation of their immunological response and their
individual susceptibility to Toxoplasma are needed to address these
topics.
Supporting Information
Text S1 Checklist S1. Strobe checklist for a cross sectional
study, including 19 French and 23 Colombian cases of confirmed
active ocular toxoplasmosis. Clinical, parasitological and immu-
nological responses are compared and correlated to the infecting
strains. Figure S1. Fundus examination in a patient with
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bilateral-extensive-multiple, central and peripheral, chorio-retinal
scars (white circled lesions) in a Colombian patient suffering from a
severe ocular toxoplasmosis; A : right eye; B : left eye. Table S1.
Complete data of all clinical and laboratory characteristics. Mann
and Whitney test followed by Bonferroni-Dunn’s Multiple
Comparison test was applied (P values,0.05 were considered
statistically significant). Table S2. Intraocular cytokines, chemo-
kines and growth factors in aqueous humor of Cataract Control
patients from France (CT-CO) and Colombia (CT-FR) and from
Ocular toxoplasmosis patients from France (OT-FR) and
Colombia (OT-CO). Levels of these immune mediators are
expressed as mean and standard deviation, median and range
(min-max) in pg/mL. Statistical differences between CT and OT
and between OT from France versus OT from Colombia were
calculated using a Kruskal-Wallis test followed by Dunn’s Multiple
Comparison test. Significant differences between populations
(P,0.05) were highlighted by tinting the spaces. Description of
major general functions of cytokines and chemokines are issued
from ‘‘Commins SP et al., J Allerg Clin Immunol, 2010;
Banchereau J. et al., Nature Immunology, 2012’’.
(DOCX)
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